KI-Zusammenfassung
Wird ausgewertet
Wird ausgewertet
Wir haben 10,000 Live-Ergebnisse für multi cancer early detection and liquid biopsy geprüft und auf 3 Optionen eingegrenzt, die sich zuerst am meisten zum Vergleichen eignen.
Die Optionen sind SPOT-MAS Multi-Cancer Early Detection, Multi-Cancer Early Detection and Liquid Biopsy, und RISE Institute Multi-Cancer Early Detection (MCED) Evaluation.
Quelle: The Medical City
Beschreibung
A liquid biopsy genomic test designed for the early detection of multiple cancer types, offered through a partnership with Gene Solutions at the TMC NGS facility.
Am besten für
Early cancer detection, Liquid biopsy screening, High Risk individuals und Preventive healthcare
Bewertung
Quelle: Lucence
Beschreibung
Proprietary genomic sequencing technology for detecting cancer signals early and guiding therapeutic selection via non-invasive blood tests.
Am besten für
Early cancer screening, Treatment selection, Liquid biopsy diagnostics und Personalized oncology
Bewertung
Quelle: National Cancer Centre Singapore (NCCS)
Beschreibung
The RISE institute at NCCS evaluates and implements Multi-Cancer Early Detection (MCED) tests, which aim to screen for multiple cancer types simultaneously through advanced blood-based technology.
Am besten für
Early cancer detection, Preventative screening, Multi Cancer blood tests und Research participants
Bewertung
| Vergleichen | #1SPOT-MAS Multi-Cancer Early Detection | #2Multi-Cancer Early Detection and Liquid Biopsy | #3RISE Institute Multi-Cancer Early Detection (MCED) Evaluation |
|---|---|---|---|
| Quelle | The Medical City | Lucence | National Cancer Centre Singapore (NCCS) |
| Beschreibung | A liquid biopsy genomic test designed for the early detection of multiple cancer types, offered through a partnership with Gene Solutions at the TMC NGS facility. | Proprietary genomic sequencing technology for detecting cancer signals early and guiding therapeutic selection via non-invasive blood tests. | The RISE institute at NCCS evaluates and implements Multi-Cancer Early Detection (MCED) tests, which aim to screen for multiple cancer types simultaneously through advanced blood-based technology. |
| Am besten für | Early cancer detection, Liquid biopsy screening, High Risk individuals und Preventive healthcare | Early cancer screening, Treatment selection, Liquid biopsy diagnostics und Personalized oncology | Early cancer detection, Preventative screening, Multi Cancer blood tests und Research participants |
| Aktion | SPOT-MAS Multi-Cancer Early Detection | Multi-Cancer Early Detection and Liquid Biopsy | RISE Institute Multi-Cancer Early Detection (MCED) Evaluation |
| Bewertung |
"SPOT-MAS Multi-Cancer Early Detection von The Medical City."
Ich habe dies ausgewählt, weil TMC combines world-class clinical care with advanced genomic screening for early cancer detection in a hospital-based setting.
Hinweis: TopFind stellt Vergleichsinformationen nur zu allgemeinen Recherchezwecken bereit.